Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase.
Myeni SK, Bredenbeek PJ, Knaap RCM, Dalebout TJ, Morales ST, Sidorov IA, Linger ME, Oreshkova N, van Zanen-Gerhardt S, Zander SAL, Enjuanes L, Sola I, Snijder EJ, Kikkert M.
Myeni SK, et al. Among authors: enjuanes l.
Nat Commun. 2023 Feb 28;14(1):1141. doi: 10.1038/s41467-023-36754-z.
Nat Commun. 2023.
PMID: 36854765
Free PMC article.